Advanced search
Publication Cover
Acta Oncologica Volume 45, 2006 - Issue 2
Journal homepage
665
Views
6
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma

Asbjørn O. Christophersen Department of Clinical Cancer Research, Radiumhospitalet – Rikshospitalet, TRUST, Oslo, Norway
,
A. Kathrine Lie Department of Pathology, Radiumhospitalet – Rikshospitalet, TRUST, Oslo, Norway
&
Sophie D. Fosså Department of Clinical Cancer Research, Radiumhospitalet – Rikshospitalet, TRUST, Oslo, Norway; University of Oslo, Oslo, NorwayCorrespondence[email protected]
Pages 226-228 | Received 29 Sep 2005, Published online: 08 Jul 2009

References

  • Thoroddsen A, Gudbjartson T, Geirsson G, Asnarsson BA, Magnusson K, et al. Spontaneous regression of pleural metastases after nephrectomy for renal cell carcinoma. Scand J Urol Nephrol 2002; 36: 396–8
  • Papac RJ. Spontaneous regression of cancer. Cancer Treat Rev 1996; 22: 395–423
  • Abubakr YA, Chou TH, Redeman RG. Spontaneous remission of renal cell carcinoma: A case report and immunological correlates. J Urol 1994; 152: 156–7
  • Everson TC, Cole WH. Spontaneous regression of cancer. W. B. Saunders Co, Philadelphia 1966; 11–87
  • Papac RJ. Spontaneous regression of cancer: Possible mechanisms. In Vivo 1998; 12: 571–8
  • Glapsy JA. Therapeutic options in the management of renal cell carcinoma. Semin Oncol 2002; 29(Suppl 7)41–6
  • Bukowski RM. Immunotherapy in renal cell carcinoma. Oncology 1999; 13: 801–10
  • Fosså SD, Lehne G, Gunderson R, Hjelmaas U, Holdener EE, et al. Recombinant interferon alpha-2a combined with prednisone in metastatic renal-cell carcinoma: Treatment results, serum interferon levels and the development of antibodies. Int J Cancer 1992; 50: 868–70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.